GLP-1 Is Changing How America Eats, Shops, and Spends
GLP-1 is no longer just a medical breakthrough. It is quietly reshaping how people live, eat, shop, and plan their futures. Over the past few weeks, something has clearly shifted. Conversations that once started as curiosity are now turning into serious strategy discussions. What many saw as a “healthcare trend” is quickly becoming a business reality across industries. With patent expirations approaching for semaglutide-based GLP-1 treatments from Novo Nordisk , access is expected to widen in the coming years. As more affordable options and generics enter the market, GLP-1 medications could move from early adopters to everyday households. That possibility is changing how brands think about long-term demand. At Jasper Colin , we reviewed two years of cross-industry research across healthcare, wellness, retail, apparel, food & beverage, and fitness. What we found isn’t just a passing trend. It looks more like a steady behavioral reset. What’s Changing in Consumer Behavior? ...